Mutations of the metabolic genes IDH1, IDH2, and SDHAF2 are not major determinants of the pseudohypoxic phenotype of sporadic pheochromocytomas and paragangliomas.

The Journal of Clinical Endocrinology and Metabolism
Li YaoPatricia L M Dahia

Abstract

Pheochromocytomas and paragangliomas are genetically heterogeneous tumors of neural crest origin. Approximately half of these tumors activate a pseudohypoxic transcription response, which is due in a minority of the cases to germline mutations of the VHL gene or the genes encoding subunits of the metabolic enzyme succinate dehydrogenase (SDH), SDHB, SDHC, or SDHD. However, the genetic basis of the hypoxic-like profile of the remaining tumors is undetermined. Mutations in genes involved in the energy metabolism, isocitrate dehydrogenase 1 (IDH1) and -2 (IDH2) and SDHAF2, a component of SDH, can mimic a pseudohypoxic state. We examined the sequence spanning the mutation-susceptible codons 132 of IDH1 and 172 of IDH2, and the entire coding region of SDHAF2, in 104 pheochromocytomas and paragangliomas, including tumors with a pseudohypoxic expression profile. We did not find mutations in IDH1, IDH2, or SDHAF2 in any of the tumors in this cohort. Conserved residues of IDH1 and IDH2 or the SDHAF2 gene are not frequently mutated in pheochromocytomas and paragangliomas. The molecular basis for activation of a hypoxic response in the majority of tumors without VHL or SDH mutations remains to be defined.

References

Nov 4, 2000·Nature Genetics·S Niemann, U Müller
Sep 5, 2002·Nature Reviews. Cancer·William G Kaelin
Aug 17, 2005·PLoS Genetics·Patricia L M DahiaCharles D Stiles
Sep 6, 2005·Biochemical and Biophysical Research Communications·Christopher J Schofield, Peter J Ratcliffe
Dec 17, 2005·Current Opinion in Oncology·Patricia L M Dahia
Mar 1, 2008·Clinical and Experimental Pharmacology & Physiology·Anne-Paule Gimenez-RoqueploPierre-François Plouin
Sep 6, 2008·Science·D Williams ParsonsKenneth W Kinzler
Feb 21, 2009·The New England Journal of Medicine·Hai YanDarell D Bigner
May 22, 2009·The New England Journal of Medicine·Emilie De CarliStéphanie Puget
Sep 22, 2009·Cancer Science·Yukihiko SonodaTeiji Tominaga
Nov 17, 2009·The Journal of Clinical Endocrinology and Metabolism·José GaalWinand N M Dinjens
Nov 26, 2009·Nature·Lenny DangShinsan M Su

❮ Previous
Next ❯

Citations

Nov 18, 2010·Familial Cancer·Erik F Hensen, Jean-Pierre Bayley
Nov 2, 2011·Endocrine-related Cancer·Jenny WelanderOliver Gimm
May 9, 2013·Endocrine-related Cancer·Eamonn R Maher
Dec 11, 2013·World Journal of Surgery·Johan KugelbergOliver Gimm
Dec 22, 2010·Proceedings of the National Academy of Sciences of the United States of America·Katherine A JanewayConstantine A Stratakis
Sep 14, 2010·Best Practice & Research. Clinical Endocrinology & Metabolism·Vitaly KantorovichKarel Pacak
Mar 17, 2010·Mitochondrion·Jared RutterJoshua D Schiffman
Jun 23, 2011·European Journal of Clinical Investigation·Tomáš ZelinkaKarel Pacak
Jul 21, 2011·Biochimica Et Biophysica Acta·Chiara BardellaIan Tomlinson
Jan 21, 2014·Nature Reviews. Cancer·Patricia L M Dahia
Jun 4, 2014·The Journal of Clinical Endocrinology and Metabolism·Jacques W M LendersWilliam F Young
Feb 12, 2017·Oncotarget·Svetlana O ZhikrivetskayaAnna V Kudryavtseva
Mar 6, 2015·World Journal of Gastroenterology : WJG·Ya-Mei WangFeng Ji
May 8, 2021·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·R Garcia-CarboneroF A Hanzu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.